rs35224402

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 5P and 20B. PM1PM5PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001128227.3(GNE):​c.717T>G​(p.Asp239Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000695 in 1,609,878 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D239G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0036 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 6 hom. )

Consequence

GNE
NM_001128227.3 missense

Scores

8
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.27

Publications

5 publications found
Variant links:
Genes affected
GNE (HGNC:23657): (glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase) The protein encoded by this gene is a bifunctional enzyme that initiates and regulates the biosynthesis of N-acetylneuraminic acid (NeuAc), a precursor of sialic acids. It is a rate-limiting enzyme in the sialic acid biosynthetic pathway. Sialic acid modification of cell surface molecules is crucial for their function in many biologic processes, including cell adhesion and signal transduction. Differential sialylation of cell surface molecules is also implicated in the tumorigenicity and metastatic behavior of malignant cells. Mutations in this gene are associated with sialuria, autosomal recessive inclusion body myopathy, and Nonaka myopathy. Alternative splicing of this gene results in transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
CLTA (HGNC:2090): (clathrin light chain A) Clathrin is a large, soluble protein composed of heavy and light chains. It functions as the main structural component of the lattice-type cytoplasmic face of coated pits and vesicles which entrap specific macromolecules during receptor-mediated endocytosis. This gene encodes one of two clathrin light chain proteins which are believed to function as regulatory elements. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 8 and 12. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_001128227.3
PM5
Other missense variant is known to change same aminoacid residue: Variant chr9-36236979-C-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 2136775.Status of the report is criteria_provided_single_submitter, 1 stars.
PP2
Missense variant in the GNE gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 44 curated pathogenic missense variants (we use a threshold of 10). The gene has 1 curated benign missense variants. Gene score misZ: 2.5904 (below the threshold of 3.09). Trascript score misZ: 4.032 (above the threshold of 3.09). GenCC associations: The gene is linked to sialuria, GNE myopathy, congenital myopathy, platelet-type bleeding disorder 19, macrothrombocytopenia, isolated.
BP4
Computational evidence support a benign effect (MetaRNN=0.010086775).
BP6
Variant 9-36236977-A-C is Benign according to our data. Variant chr9-36236977-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 287949.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00357 (544/152360) while in subpopulation AFR AF = 0.0122 (508/41590). AF 95% confidence interval is 0.0113. There are 5 homozygotes in GnomAd4. There are 253 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNENM_001128227.3 linkc.717T>G p.Asp239Glu missense_variant Exon 4 of 12 ENST00000396594.8 NP_001121699.1 Q9Y223-2
GNENM_005476.7 linkc.624T>G p.Asp208Glu missense_variant Exon 4 of 12 ENST00000642385.2 NP_005467.1 Q9Y223-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNEENST00000396594.8 linkc.717T>G p.Asp239Glu missense_variant Exon 4 of 12 1 NM_001128227.3 ENSP00000379839.3 Q9Y223-2
GNEENST00000642385.2 linkc.624T>G p.Asp208Glu missense_variant Exon 4 of 12 NM_005476.7 ENSP00000494141.2 Q9Y223-1

Frequencies

GnomAD3 genomes
AF:
0.00355
AC:
541
AN:
152242
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0122
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000896
AC:
225
AN:
251226
AF XY:
0.000604
show subpopulations
Gnomad AFR exome
AF:
0.0120
Gnomad AMR exome
AF:
0.000752
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000395
AC:
575
AN:
1457518
Hom.:
6
Cov.:
28
AF XY:
0.000323
AC XY:
234
AN XY:
725410
show subpopulations
African (AFR)
AF:
0.0143
AC:
479
AN:
33388
American (AMR)
AF:
0.000738
AC:
33
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26088
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39634
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86172
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53346
Middle Eastern (MID)
AF:
0.000529
AC:
3
AN:
5670
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1108252
Other (OTH)
AF:
0.000846
AC:
51
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
28
56
85
113
141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00357
AC:
544
AN:
152360
Hom.:
5
Cov.:
32
AF XY:
0.00340
AC XY:
253
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.0122
AC:
508
AN:
41590
American (AMR)
AF:
0.00190
AC:
29
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68036
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00196
Hom.:
4
Bravo
AF:
0.00428
ESP6500AA
AF:
0.0136
AC:
60
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000914
AC:
111
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 24, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 18, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sialuria;C1853926:GNE myopathy Benign:2
Nov 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Oct 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GNE: BS1, BS2 -

Jul 13, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24796702, 27858732, 33094863) -

See cases Benign:1
Feb 25, 2020
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACMG classification criteria: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.070
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.77
D;.;D;.;.;D
Eigen
Benign
-0.077
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.96
.;D;D;D;D;.
MetaRNN
Benign
0.010
T;T;T;T;T;T
MetaSVM
Uncertain
0.75
D
MutationAssessor
Benign
0.72
N;.;N;.;N;N
PhyloP100
2.3
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-0.50
.;N;N;.;N;N
REVEL
Uncertain
0.45
Sift
Benign
0.46
.;T;T;.;T;T
Sift4G
Benign
1.0
.;T;T;T;T;T
Polyphen
0.0
B;B;B;.;.;B
Vest4
0.51, 0.44, 0.48, 0.48, 0.43
MutPred
0.56
Gain of methylation at K210 (P = 0.08);.;Gain of methylation at K210 (P = 0.08);.;Gain of methylation at K210 (P = 0.08);Gain of methylation at K210 (P = 0.08);
MVP
1.0
MPC
0.50
ClinPred
0.014
T
GERP RS
6.1
Varity_R
0.12
gMVP
0.64
Mutation Taster
=63/37
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35224402; hg19: chr9-36236974; API